Citius Pharmaceuticals (CTXR) Amortizatization of Intangibles (2013 - 2021)
Citius Pharmaceuticals' (CTXR) quarterly Amortizatization of Intangibles came in at $42879.0 in Q4 2021, up 8.09% YoY from $39671.0 in Q4 2020, and up 2.0% on a QoQ basis from $42037.0 in Q3 2021.
Citius Pharmaceuticals (CTXR) Amortizatization of Intangibles (2013 - 2021) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 5 years of Amortizatization of Intangibles data on file, last reported at $42879.0 in Q4 2021.
- Quarterly Amortizatization of Intangibles rose 8.09% year-over-year to $42879.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $166584.0 (up 6.36% YoY) and the FY2021 annual result came in at $163376.0, up 7.82% from the prior year.
- Amortizatization of Intangibles advanced to $42879.0 in Q4 2021, from $42037.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $47278.0 in Q1 2020 to a low of $30758.0 in Q2 2020.
- A 3-year average of $39752.8 and a median of $40441.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 34.04% in 2021, down 14.46% in 2021.
- Tracing CTXR's Amortizatization of Intangibles over 3 years: stood at $34569.0 in 2019, then climbed by 14.76% to $39671.0 in 2020, then gained by 8.09% to $42879.0 in 2021.
- The last three Amortizatization of Intangibles figures came in at $42879.0 (Q4 2021), $42037.0 (Q3 2021), and $41227.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Citius Pharmaceuticals | 15.71 Mn | 15.71 Mn | 1.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 42,879.00 |
| Dec 31, 2021 | 42,879.00 |
| Sep 30, 2021 | 42,037.00 |
| Sep 30, 2021 | 42,037.00 |
| Jun 30, 2021 | 41,227.00 |
| Jun 30, 2021 | 41,227.00 |
| Mar 31, 2021 | 40,441.00 |
| Mar 31, 2021 | 40,441.00 |
| Dec 31, 2020 | 39,671.00 |
| Dec 31, 2020 | 39,671.00 |
| Sep 30, 2020 | 38,915.00 |
| Sep 30, 2020 | 38,915.00 |
| Jun 30, 2020 | 30,758.00 |
| Jun 30, 2020 | 30,758.00 |
| Mar 31, 2020 | 47,278.00 |
| Mar 31, 2020 | 47,278.00 |
| Dec 31, 2019 | 34,569.00 |
| Dec 31, 2019 | 34,569.00 |
| Sep 30, 2014 | 14,000.00 |
| Sep 30, 2014 | 14,000.00 |